{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:01:28Z","timestamp":1767988888133,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute against Occupational Injury Insurance"},{"name":"Cancer Council Queensland, National Health and Medical Research Council of Australia"},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"crossref","award":["P301\/10\/1937"],"award-info":[{"award-number":["P301\/10\/1937"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Griffith University Senior Research Fellowship"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.lungcan.2015.09.021","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T04:05:44Z","timestamp":1443240344000},"page":"457-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma"],"prefix":"10.1016","volume":"90","author":[{"given":"Lory","family":"Santarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Staffolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Nocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Manzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elettra","family":"Pignotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Alleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Battista","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Sabbatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Rubini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zuccatosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Bichisecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Horwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manola","family":"Comar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bovenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Amati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tomasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2015.09.021_bib0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1289\/ehp.1002285","article-title":"The case for a global ban on asbestos","volume":"118","author":"LaDou","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0010","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0015","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","article-title":"Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma","volume":"173","author":"Scherpereel","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","article-title":"Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study","volume":"17","author":"Amati","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0030","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0035","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2012.02.009","article-title":"Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients","volume":"45","author":"Tomasetti","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0045","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2008.12.098","article-title":"Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells","volume":"379","author":"Saito","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0050","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3892\/or.2013.2633","article-title":"Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer","volume":"30","author":"Zhang","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ncb2690","article-title":"miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0060","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1089\/ars.2013.5215","article-title":"MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Tomasetti","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2490-13-37","article-title":"Dysregulated methylation at imprinted genes in prostate tumor tissue detected by methylation microarray","volume":"13","author":"Jacobs","year":"2013","journal-title":"BMC Urol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0070","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ajpath.2013.04.033","article-title":"Epigenetic modifications in breast cancer and their role in personalized medicine","volume":"183","author":"Stefansson","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0075","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.canep.2013.05.012","article-title":"Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma","volume":"37","author":"Tian","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.lungcan.2013.05.016","article-title":"Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients","volume":"81","author":"Ponomaryova","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0085","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1373\/clinchem.2008.104653","article-title":"Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma","volume":"54","author":"Chan","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0090","first-page":"1087","article-title":"Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas","volume":"12","author":"Kobatake","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4161\/epi.6.8.16074","article-title":"The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma","volume":"6","author":"Nelson","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0105","doi-asserted-by":"crossref","first-page":"19478","DOI":"10.1074\/jbc.M110.217331","article-title":"Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose) polymerase-1-mediated epigenetic mechanism","volume":"286","author":"Nocchi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mrgentox.2008.06.011","article-title":"Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk","volume":"655","author":"Amati","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0115","first-page":"5517","article-title":"YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis","volume":"33","author":"Corradi","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0120","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","article-title":"Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma","volume":"6","author":"Cristaudo","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JTO.0b013e31824c9272","article-title":"CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions","volume":"7","author":"Blanquart","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/JTO.0b013e31828f696b","article-title":"Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer","volume":"8","author":"Muley","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0135","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3892\/mco.2013.175","article-title":"Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma","volume":"1","author":"Fukuoka","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2007.08.035","article-title":"Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up","volume":"59","author":"Destro","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0145","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/oem.2009.049205","article-title":"Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein","volume":"67","author":"Cristaudo","year":"2010","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2010.06.004","article-title":"miR-126 functions as a tumour suppressor in human gastric cancer","volume":"298","author":"Feng","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbrc.2008.09.089","article-title":"The cell growth suppressor, mir-126, targets IRS-1","volume":"377","author":"Zhang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-011-0723-7","article-title":"Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2","volume":"351","author":"Zhu","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0180","first-page":"77","article-title":"Identification of aberrantly expressed miRNAs in rectal cancer","volume":"28","author":"Li","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11010-013-1707-6","article-title":"Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4","volume":"381","author":"Li","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0190","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/onc.2013.335","article-title":"Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talk confers angiogenesis of cervical cancer","volume":"33","author":"Huang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature06487","article-title":"Endogenous human microRNAs that suppress breast cancer metastasis","volume":"451","author":"Tavazoie","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2015.09.021_bib0200","doi-asserted-by":"crossref","first-page":"E3395","DOI":"10.1073\/pnas.1217982109","article-title":"Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling","volume":"109","author":"Zong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pathol.1.110304.100224","article-title":"Tumor stroma and regulation of cancer development","volume":"1","author":"Tlsty","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0210","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/jso.21709","article-title":"Tumor microenvironment and progression","volume":"103","author":"Dvorak","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0215","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1538-7836.2003.00306.x","article-title":"Thrombomodulin","volume":"1","author":"Weiler","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0220","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mc.20663","article-title":"Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in non-small cell lung cancer","volume":"49","author":"Liu","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lungcan.2015.09.021_bib0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/oem.2009.049205","article-title":"Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein","volume":"67","author":"Cristaudo","year":"2010","journal-title":"Occup. Environ. Med."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:38:46Z","timestamp":1567211926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0169500215300659"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.021","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}